Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03076372
Title A Study Evaluating MM-310 in Patients With Solid Tumors
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications

transitional cell carcinoma

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

lung small cell carcinoma

ovarian cancer

pancreatic ductal adenocarcinoma

sarcoma

stomach carcinoma

endometrial carcinoma

esophageal carcinoma

lung non-small cell carcinoma

Therapies

MM-310

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Recruiting Scottsdale Arizona 85259 United States Details
University California San Francisco Recruiting San Francisco California 94143 United States Details
Mayo Clinic Recruiting Rochester Minnesota 55902 United States Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
Duke University Recruiting Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field